Patent Assignment
Reel/Frame 035051/0584
Assignment of Assignor's Interest
Recorded: 2015-02-18
Pages: 4
Assignee
FRED HUTCHINSON CANCER RESEARCH CENTER
1100 FAIRVIEW AVENUE NORTH, J5-110, SEATTLE, WASHINGTON, 98109
Covered Property
(1)
Cyclin A1-Targeted T-Cell Immunotherapy for Cancer
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Confirmatory License
Dec 1, 2016
From: FRED HUTCHINSON CANCER RESEARCH CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 040782/0921 →
Merger and Change of Name
Jun 9, 2022
From: FRED HUTCHINSON CANCER RESEARCH CENTER; SEATTLE CANCER CARE ALLIANCE
To: FRED HUTCHINSON CANCER CENTER
Reel/Frame 060329/0793 →
Merger and Change of Name
Aug 4, 2022
From: FRED HUTCHINSON CANCER RESEARCH CENTER; SEATTLE CANCER CARE ALLIANCE
To: FRED HUTCHINSON CANCER CENTER
Reel/Frame 060722/0441 →